Within each patient group, no significantly higher IFN gamma concentrations were observed after stimulation with the different antigens at T3, except between Ag1 and Ag 3 for the healthy control, neurologic and CKD patient groups, and between Ag1 and Ag2 for the healthy control group (Figure 3). The gene discussed is IFNG; the disease is chronic kidney disease.